SG11202001149TA - Systems and methods for the assessment of g-protein activation - Google Patents

Systems and methods for the assessment of g-protein activation

Info

Publication number
SG11202001149TA
SG11202001149TA SG11202001149TA SG11202001149TA SG11202001149TA SG 11202001149T A SG11202001149T A SG 11202001149TA SG 11202001149T A SG11202001149T A SG 11202001149TA SG 11202001149T A SG11202001149T A SG 11202001149TA SG 11202001149T A SG11202001149T A SG 11202001149TA
Authority
SG
Singapore
Prior art keywords
assessment
systems
methods
protein activation
activation
Prior art date
Application number
SG11202001149TA
Inventor
Gouill Christian Le
Michel Bouvier
Viktoriya Lukasheva
Mireille Hogue
Billy Breton
Original Assignee
Univ Montreal
Domain Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montreal, Domain Therapeutics filed Critical Univ Montreal
Publication of SG11202001149TA publication Critical patent/SG11202001149TA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202001149TA 2017-10-18 2018-10-15 Systems and methods for the assessment of g-protein activation SG11202001149TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762573853P 2017-10-18 2017-10-18
PCT/CA2018/051294 WO2019075556A1 (en) 2017-10-18 2018-10-15 Systems and methods for the assessment of g-protein activation

Publications (1)

Publication Number Publication Date
SG11202001149TA true SG11202001149TA (en) 2020-03-30

Family

ID=66173171

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202001149TA SG11202001149TA (en) 2017-10-18 2018-10-15 Systems and methods for the assessment of g-protein activation

Country Status (10)

Country Link
US (1) US20200256869A1 (en)
EP (1) EP3697934B1 (en)
JP (1) JP2020537531A (en)
KR (1) KR20200071724A (en)
CN (1) CN111164226A (en)
AU (1) AU2018353813A1 (en)
CA (1) CA3076672A1 (en)
IL (1) IL272659A (en)
SG (1) SG11202001149TA (en)
WO (1) WO2019075556A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10430987B1 (en) 2017-06-09 2019-10-01 Snap Inc. Annotating an image with a texture fill
CN117024557B (en) * 2023-10-10 2024-01-30 天津外泌体科技有限公司 Application of 14-3-3 protein theta isomer as extracellular vesicle scaffold protein and extracellular vesicle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196524A (en) 1989-01-06 1993-03-23 Eli Lilly And Company Fusion reporter gene for bacterial luciferase
US5219737A (en) 1990-03-27 1993-06-15 Kikkoman Corporation Mutant luciferase of a firefly, mutant luciferase genes, recombinant dnas containing the genes and a method of producing mutant luciferase
US5229285A (en) 1991-06-27 1993-07-20 Kikkoman Corporation Thermostable luciferase of firefly, thermostable luciferase gene of firefly, novel recombinant dna, and process for the preparation of thermostable luciferase of firefly
JP3466765B2 (en) 1994-07-27 2003-11-17 キッコーマン株式会社 Biotinylated firefly luciferase, biotinylated firefly luciferase gene, novel recombinant DNA, method for producing biotinylated firefly luciferase and bioluminescence analysis method
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
ATE388224T1 (en) 1998-03-27 2008-03-15 Prolume Ltd LUCIFERASE, GFP FLUORESCENT PROTEINS, CODING NUCLEIC ACID AND THEIR USE IN DIAGNOSTICS
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
US6645761B1 (en) 2000-12-22 2003-11-11 Stratagene Humanized polynucleotide sequence encoding Renilla mulleri green fluorescent protein
WO2005121755A1 (en) * 2004-06-14 2005-12-22 Commonwealth Scientific And Industrial Research Organisation Cell free g-protein coupled receptor and ligand assay
WO2006086883A1 (en) * 2005-02-16 2006-08-24 Universite De Montreal Biosensors for monitoring receptor-mediated g-protein activation
DK3194960T3 (en) * 2014-09-19 2020-02-17 The Royal Institution For The Advancement Of Learning / Mcgill Univ BIOSENSORS FOR MONITORING LOCATION AND TRANSPORTATION OF BIOMOLECULES IN CELLS
ES2832331T3 (en) 2014-10-14 2021-06-10 Univ Montreal Protein-based biosensor that interacts with gbetagamma to monitor G protein activation

Also Published As

Publication number Publication date
KR20200071724A (en) 2020-06-19
AU2018353813A1 (en) 2020-04-09
IL272659A (en) 2020-03-31
JP2020537531A (en) 2020-12-24
EP3697934A4 (en) 2021-06-30
CN111164226A (en) 2020-05-15
EP3697934A1 (en) 2020-08-26
WO2019075556A1 (en) 2019-04-25
EP3697934B1 (en) 2024-03-27
CA3076672A1 (en) 2019-04-25
US20200256869A1 (en) 2020-08-13

Similar Documents

Publication Publication Date Title
EP3545418A4 (en) Systems and methods for cybersecurity risk assessment
GB201714658D0 (en) Passenger tracking systems and methods
GB201706579D0 (en) Systems and methods for phone-as-a-key range extension
HK1252213A1 (en) Systems and methods for recommending an estimated time of arrival
IL276690A (en) Neural microphysiological systems and methods of using the same
GB2575561B (en) Visually correlated radar systems and methods
EP3485601A4 (en) Systems and methods for initialization and activation of secure elements
GB201721021D0 (en) Computer-implemented methods and systems
GB2539590B (en) Lower Limb Loading assessment systems and methods
EP3405782A4 (en) Inspection devices and related systems and methods
IL265969A (en) Systems and methods for distributing radioheads
GB2565837B (en) Systems and methods for navigation
EP3519836A4 (en) Probe systems and methods
GB2559382B (en) Systems and methods for cell range extension
IL272007A (en) Systems and methods for locating and/or characterizing intragastric devices
IL272659A (en) Systems and methods for the assessment of g-protein activation
GB201609032D0 (en) Levelling systems and methods
EP3435300A4 (en) Assessment device and assessment system
IL247760A0 (en) Methods and systems for conducting an assessment
GB2564600B (en) Systems and methods for unfaulting point clouds
IL250459A0 (en) Navigation systems and methods
GB2563772B (en) Distributed sensor systems and methods
GB201714660D0 (en) Computer-implemented methods and systems
GB201713064D0 (en) Computer-implemented methods and systems
GB201714044D0 (en) Systems and methods for assessing cognitive function